VAPAWAY.EU - Research and education on VAP prevention
  • Home
  • Articles
  • GuideLines
  • Links
  • About VAPAWAY
  • Training
  • Contacts

Login








Lost Password?

Register to receive updated data on VAPAWAY initiative

Agenda

 

9 - 12 March 2010

ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)

ISICEM

 

9 -11 June 2010

EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)

EACTA

 

12-15 June 2010

ESA European Society of Anaesthesiology - Helsinki (Finland)

ESA

 

18-22 September 2010

ERS European Respiratory Society - Barcellona (Spain)

ERS

 

9 -13 October 2010

ESICM European Society of Intensive Care Medicine - Barcellona (Spain)

ESICM

  

 

> International events   

> Local events 

Articles - blog
LIKELIHOOD OF INADEQUATE TREATMENT: A NOVEL APPROACH TO EVALUATING DRUG-RESISTANCE PATTERNS PDF Print E-mail
Thursday, 10 September 2009

Burgmann H et al

About this article:"In this prospective study authors prospectively performed  bronchoalveolar lavages from patients with suspecte VAP. They designed a prediction model of  indequate therapy (LIT) according to the drug resistance rates obtained from the MIC measurements of te most common antibiotics used to treat VAP. The best antibiotic for adequate therapy and the worse piperacillin-tazobactam. The prediction ratio used has to be validated  in each unit before its clinical use"
Read more...
 
CEFTOBIPROLE:A NEW BOARD SPECTRUM CEPHALOSPORIN PDF Print E-mail
Thursday, 10 September 2009

El Solh A. 

About this article:"Ceftobiprole is a new cephalosporine with a potential activity against Enterobacteriaceae, Pseudomonas aeruginosa and MRSA.Clinicians have to be aware that in a phase clinical trial ceftobiprole resulted less effective than comparators for the treatment of ventilator-associated pneumonia. Accordingly, ceftobiprole cannot be used for the empirical treatment of VAP "

Read more...
 
MATRIX METALLOPROTEASES IN BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH TYPE III PSEUDOMONAS AERUGI PDF Print E-mail
Thursday, 10 September 2009

El-Solh AA et al 

About this article:"Pseudomonas aeruginosa  is a frequent etiology of ventilator-associated pneumonia associated to high morbidity, mortality and cost. Some studies suggest that type III Pseudomonas aeruginosa is linked to poor outcome. Authors performed  serial BAL fluids assaying for MMP8 and 9, tissue inhibitor of metalloproteinase (TIMP-1) and alpha-2 macroglobulin levels. Patients who survived had a lower ratio MMP9/TIMP-1 ratio. Authors conclude that imbalances in this ratio may be related to alveolocapillary-damage and perhaps this may influence the prognosis of VAP caused by Pseudomonas aeruginosa"

Read more...
 
NOT-SO-TRIVIAL PURSUIT: MECHANICAL VENTILATION RISK REDUCTION PDF Print E-mail
Thursday, 10 September 2009

Grap MJ 

About this article:"This a review article on several important elements for the prevention of ventilator-assciated pneumonia. These elements include airway management, back-rest elevation, oral care strategies  and sedation protocols. Authors examine the pro and con and the feasibility of these methods."

Read more...
 
ORAL HEALTH,VAP AND INTRACRANIAL PRESSURE IN INTUBATED PATIENTS IN A NEUROSCIENCE INTENSIVE CARE PDF Print E-mail
Thursday, 10 September 2009

Prendergast V. et al 

About this article:"Oral care is an important element  for the prevention of VAP. However, and despite this recognition  oral care has been regarded as a secondary issue. In this observational study in  neurocritically ill patients oral health assesed by  Oral Assesment guide  worsened importantly after 48 of intubation and improved after extubation. The authors did not observed increases in intracraneal pressure  during the procedures  of oral care and concluded that oral care can be safely performed in these type of patients"

Read more...
 
RISK FACTORS FOR RELAPSE OF VAP IN TRAUMA PATIENTS PDF Print E-mail
Thursday, 10 September 2009

Rangel EL et al 

About this article:"Relapsing or recurrent VAP have been studied in previous publication of general populations of critically ill mechanically ventilated patients. However,there is no information on critically ill trauma patients. Indices of severity were not related with recurrence or relapse. Only a primary VAP caused by non-fermeting Gram negative bacilli was associated in the uni and multivariates with VAP relapse or recurrence. It is obvious that these type of patients require a longer clinical and microbiological surveillance to discard relapse or recurrence"

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 81 - 90 of 307
Select and watch
from the following webinars

 


Join us on www.smartonweb.org

Partner

VAPAWAY is proudly supported by Covidien.

http://www.covidien.com